A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)

ABSTRACT: This is an open-label, single center, non-randomized, phase Ⅱ trial to evaluate safety and efficacy of using the combination treatment of Camrelizumab with anti-angiogenic drugs and Chemotherapy of metastatic colorectal mucinous adenocarcinoma(MAC).

DISEASE(S): Adenocarcinoma,Cystadenocarcinoma,Colorectal Cancer,Adenocarcinoma, Mucinous

PROVIDER: 2343664 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR